Medical and Pharmaceutical bioAffinity jumps 45% from lung cancer phlegm test expansion It is the only commercially available test of its kind Rowan DunneSeptember 2, 2026
AI and Autonomy AI flags heart disease from routine ECG test within seconds Artificial intelligence is making it easier to determine who needs a heart ultrasound most Rowan DunneSeptember 1, 2026
Medical and Pharmaceutical Canadian government invests C$35M in expansion of Kardium’s Vancouver facility Kardium makes an advanced heart disorder treatment device Rowan DunneAugust 31, 2026
Medical and Pharmaceutical Revolution’s newly approved drug doubles pancreatic cancer survival time A 30-day course of Rasonque costs US$39,800 Rowan DunneAugust 31, 2026
Medical and Pharmaceutical Propanc Biopharma skyrockets from pancreatic cancer drug breakthrough Stock ascended by more than 150% Rowan DunneAugust 28, 2026
Medical and Pharmaceutical Galvanize Therapeutics finds signs Aliya PEF may activate immune response in lung cancer The findings could help researchers understand whether Aliya treatments can complement existing cancer immunotherapies Joseph MortonAugust 26, 2026
Medical and Pharmaceutical Korean medtech operator Rayence launches portable ‘Anywhere’ X-ray Rayence's latest and greatest mobile devices feature a proprietary new de-noising feature Rowan DunneAugust 26, 2026
Medical and Pharmaceutical Artificial heart maker Picard soars from 39% revenue spike, narrowed net loss SynCardia's Total Artificial Heart serves as a temporary solution while patients wait for donors Rowan DunneAugust 24, 2026
Medical and Pharmaceutical Young Muay Thai fighter’s lung cancer death raises screening eligibility concerns Many heavy smokers live into their senior years while others are taken far too young Rowan DunneAugust 23, 2026
Medical and Pharmaceutical Craif raises US$33M to get its urine cancer test into American clinics Milestone follows the firm opening a California lab in April Rowan DunneAugust 20, 2026